| dc.contributor.author | Paglialunga, S. | |
| dc.contributor.author | van Bree, B. | |
| dc.contributor.author | Valdecantos, P. | |
| dc.contributor.author | Amengual-Cladera, E. | |
| dc.contributor.author | Jörgensen, J.A. | |
| dc.contributor.author | van Beurden, D. | |
| dc.contributor.author | den Hartog, G.J.M. | |
| dc.contributor.author | Ouwens, D.M. | |
| dc.contributor.author | Briedé, J.J. | |
| dc.contributor.author | Schrauwen, P. | |
| dc.contributor.author | Hoeks, J. | |
| dc.contributor.author | Bosma, M. | |
| dc.date.accessioned | 2024-02-06T08:57:44Z | |
| dc.identifier.uri | http://hdl.handle.net/11201/164539 | |
| dc.description.abstract | [eng] Aims/hypothesis High-fat, high-sucrose diet (HF)-induced reactive oxygen species (ROS) levels are implicated in skeletal muscle insulin resistance and mitochondrial dysfunction. Here we investigated whether mitochondrial ROS sequestering can circumvent HF-induced oxidative stress; we also determined the impact of any reduced oxidative stress on muscle insulin sensitivity and mitochondrial function. Methods The Skulachev ion (plastoquinonyl decyltriphe nylphosphonium) (SkQ), a mitochondria-specific antioxidant, was used to target ROS production in C2C12 muscle cells as well as in HF-fed (16 weeks old) male C57Bl/6 mice, compared with mice on low-fat chow diet (LF) or HF alone. Oxidative stress was measured as protein carbonylation levels. Glucose tolerance tests, glucose uptake assays and insulin-stimulated signalling were determined to assess muscle insulin sensitivity. Mitochondrial function was determined by high-resolution respirometry. Results SkQ treatment reduced oxidative stress in muscle cells (−23% p<0.05), but did not improve insulin sensi tivity and glucose uptake under insulin-resistant condi tions. In HF mice, oxidative stress was elevated (56% vs LF p<0.05), an effect completely blunted by SkQ. How ever, HF and HF+SkQ mice displayed impaired glucose tolerance (AUC HF up 33%, p<0.001; HF+SkQ up 22%; p<0.01 vs LF) and disrupted skeletal muscle insulin signalling. ROS sequestering did not improve mitochondrial function. Conclusions/interpretation SkQ treatment reduced muscle mitochondrial ROS production and prevented HF-induced oxidative stress. Nonetheless, whole-body glucose toler ance, insulin-stimulated glucose uptake, muscle insulin signalling and mitochondrial function were not improved. These results suggest that HF-induced oxidative stress is not a prerequisite for the development of muscle insulin resistance. | |
| dc.format | application/pdf | |
| dc.relation.isformatof | Versió postprint del document publicat a: https://doi.org/10.1007/s00125-012-2626-x | |
| dc.relation.ispartof | Diabetologia, 2012, vol. 55, p. 2759-2768 | |
| dc.subject.classification | 57 - Biologia | |
| dc.subject.classification | Ciències de la salut | |
| dc.subject.other | 57 - Biological sciences in general | |
| dc.subject.other | Medical sciences | |
| dc.title | Targeting mitochondrial ROS production does not avert lipid-induced insulin resistance in muscle | |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:eu-repo/semantics/acceptedVersion | |
| dc.date.updated | 2024-02-06T08:57:45Z | |
| dc.date.embargoEndDate | info:eu-repo/date/embargoEnd/2100-01-01 | |
| dc.embargo | 2100-01-01 | |
| dc.rights.accessRights | info:eu-repo/semantics/embargoedAccess | |
| dc.identifier.doi | https://doi.org/10.1007/s00125-012-2626-x |